BlackRock’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
2,628,352
+256,526
+11% +$1.05M ﹤0.01% 3621
2026
Q1
$10.2M Sell
2,371,826
-20,885
-0.9% -$104K ﹤0.01% 3495
2025
Q4
$13.9M Buy
2,392,711
+251,081
+12% +$1.2M ﹤0.01% 3295
2025
Q3
$8.2M Buy
2,141,630
+260,731
+14% +$997K ﹤0.01% 3554
2025
Q2
$6.73M Buy
1,880,899
+1,648,323
+709% +$4.68M ﹤0.01% 3622
2025
Q1
$591K Buy
232,576
+12,500
+6% +$46.4K ﹤0.01% 4354
2024
Q4
$847K Buy
220,076
+34,053
+18% +$111K ﹤0.01% 4262
2024
Q3
$508K Sell
186,023
-814
-0.4% -$2.01K ﹤0.01% 4323
2024
Q2
$495K Sell
186,837
-1,430,969
-88% -$3.27M ﹤0.01% 4348
2024
Q1
$3.82M Sell
1,617,806
-65,428
-4% -$140K ﹤0.01% 3786
2023
Q4
$4.13M Buy
1,683,234
+123,317
+8% +$294K ﹤0.01% 3760
2023
Q3
$4.21M Buy
1,559,917
+154,005
+11% +$422K ﹤0.01% 3719
2023
Q2
$4.85M Buy
1,405,912
+1,060,167
+307% +$4.16M ﹤0.01% 3736
2023
Q1
$1.46M Buy
345,745
+459
+0.1% +$1.81K ﹤0.01% 4195
2022
Q4
$1.23M Buy
345,286
+835
+0.2% +$2.3K ﹤0.01% 4343
2022
Q3
$768K Sell
344,451
-6,492
-2% -$16.1K ﹤0.01% 4578
2022
Q2
$888K Buy
350,943
+502
+0.1% +$1.22K ﹤0.01% 4583
2022
Q1
$1M Sell
350,441
-3,312
-0.9% -$9.92K ﹤0.01% 4663
2021
Q4
$1.06M Sell
353,753
-10,156
-3% -$31.1K ﹤0.01% 4646
2021
Q3
$1.04M Buy
363,909
+20
+0% +$66 ﹤0.01% 4540
2021
Q2
$1.69M Sell
363,889
-1,309,423
-78% -$5.14M ﹤0.01% 4347
2021
Q1
$5.89M Buy
1,673,312
+82,562
+5% +$358K ﹤0.01% 3866
2020
Q4
$9.57M Buy
1,590,750
+15,555
+1% +$87.1K ﹤0.01% 3382
2020
Q3
$11.4M Buy
1,575,195
+39,165
+3% +$347K ﹤0.01% 3153
2020
Q2
$13.8M Buy
1,536,030
+1,521,836
+10,722% +$15.4M ﹤0.01% 3004
2020
Q1
$106K Buy
14,194
+1,140
+9% +$7.67K ﹤0.01% 4341
2019
Q4
$85K Buy
+13,054
New +$63.6K ﹤0.01% 4468

Other funds holding KRMD

BlackRock's KRMD Position: Q2 2026 in Review

BlackRock increased its KORU Medical Systems (KRMD) stake by 11% in Q2 2026, buying an estimated $1.05M and bringing the position to 2,628,352 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #3621.

BlackRock first reported a position in KRMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $13.9M in Q4 2025. 85 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • BlackRock held 2,628,352 shares of KORU Medical Systems worth $11M as of Q2 2026.
  • BlackRock bought 256,526 KORU Medical Systems shares in Q2 2026, an estimated $1.05M.
  • KORU Medical Systems made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3621 holding.
  • BlackRock first reported a position in KORU Medical Systems in Q4 2019 and has held it in 27 quarters since.
  • BlackRock's KORU Medical Systems position peaked at $13.9M in Q4 2025.
  • 85 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.